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Autosomal dominant retinitis pigmentosa with
apparent incomplete penetrance: a clinical,
electrophysiological, psychophysical, and molecular
genetic study
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Abstract
Twenty five symptomatic individuals and six
asymptomatic obligate gene carriers from four
families with autosomal dominant retinitis pig-
mentosa (adRP) showing apparent incomplete
penetrance have been studied. Symptomatic
individuals from three families showed early
onset of night blindness, non-recordable rod
electroretinograms, and marked elevation of
both rod and cone thresholds in all subjects
tested. In the fourth family, there was more
variation in the age of onset of night blindness
and some symptomatic individuals showed
well preserved rod and cone function in some
retinal areas. All asymptomatic individuals
tested had evidence of mild abnormalities of
rod and cone function, indicating that these
families show marked variation in expressivity
rather than true non-penetrance of the adRP-
gene. No mutations of the rhodopsin or RDS
genes were found in these families and the
precise genetic mutation(s) remain to be identi-
fied.
(Br_' Ophthalmol 1993; 77: 473-479)
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Clinical and psychophysical studies in autosomal
dominant retinitis pigmentosa (adRP) have sug-
gested that there may be genetic heterogeneity
within the disorder.`'5 This has been confirmed
by the finding ofmutations in the rhodopsin gene
on chromosome 367 and the retinal degeneration
slow (RDS) gene on chromosome 6"1o in some
families with adRP. Some forms of adRP do not
show linkage to or mutations of either the
rhodopsin gene or the RDS gene and additional
genetic mutations remain to be identified.
Most families, including those with known
mutations, show complete penetrance of the
adRP gene. In a few families incomplete pene-
trance is a notable feature"-'5 and it has been
suggested on the basis ofthe electroretinographic
findings that this may be a distinct form of
adRP." 12
We have studied both symptomatic indi-
viduals and asymptomatic obligate gene carriers
from four families showing apparent incomplete
penetrance in order to characterise the pattern of
retinal disease in affected family members and to
investigate rod and cone function in those
obligate gene carriers who remain asymptomatic
in the fourth or fifth decade of life. We have also
investigated whether any of the families show
mutations of the rhodopsin or RDS genes, or
linkage to chromosomes 3 or 6.
Patients and methods
Twenty five symptomatic individuals (mean age
32 years; range 13-58 years) and six asympto-
matic obligate gene carriers (mean age 46 years;
range 39-60 years) from four families with
apparent incomplete penetrance took part in the
study. In each family there was transmission of
the disease through at least three generations (Fig
1), and in three there was evidence of male to
male transmission, In the fourth, although there
was no male to male transmission, all the affected
females had severe disease, suggesting autosomal
dominant inheritance.
Each subject underwent a full clinical evalua-
tion. A variety of investigations including an
electroretinography (ERG), electro-oculography
(EOG), Goldmann perimetry, and detailed dark
adapted static perimetry were performed in the
majority of subjects (subjects with advanced RP
with extensive field loss did not undergo psycho-
physical testing). In addition, photopic flicker
testing was performed on each of the six asymp-
tomatic obligate gene carriers. Detailed Gold-
mann perimetry was performed on each eye
using the IV 4e and I 4e targets. The ERG was
Family 1
IV
Figure 1
473
Moore, Fitzke, Jay, Arden, Inglehearn, Keen, Bhattacharya, Bird
Xl
IIIA
IIA
IA
A
Al
III
Family 2
11
111
IV
V
VI
VIII
Vill
Vil
Family 3
11
III
IV
V
Family 4
III 5 i 27 29 tIVI
Figure 1 Pedigrees offamilies 1, 2, 3, and 4. O :symptomatic individual; 3 0: asymptomatic obligate gene carrier; -: propositus; +: examinedby the authors.
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Table I Age ofonset ofnight blindness
Onset ofnight blindness
No ofpatients
Family <10years 11-20years >21 years examined
1 4 0 0 4
2 2 3 5 10
3 2 0 0 2
4 4 4 0 9*
*One patient denied any night blindness.
performed in accordance with the protocol des-
cribed in Arden et al'6 and the details of the
method used for photopic fficker are given in
Tyler et al."7 Dark adapted perimetry was per-
formed on one eye (which showed least field loss
on Goldmann perimetry) of each subject using
red (dominant wavelength 660 mm, subtending
0.9) and green (dominant wavelength 530 nm,
subtending 0.90) targets. The pupil was dilated
with 1% cyclopentolate and the eye dark adapted
for 40 minutes before starting the test. At least 17
points at different retinal locations in both upper
and lower fields were tested in each case. The
apparatus and method for the dark adapted static
perimetry have been described previously. 8
Symptomatic members from each family were
screened for mutations in the rhodopsin and
RDS genes. Exon sequences were amplified by
the polymerase chain reaction using primers
flanking the exons.9192' Amplified fragments
were run on hydrolink gels in order to detect
mutations as heteroduplexed fragments of
normal and mutated DNA sequences.2' This
method has successfully detected 13 different
mutations in the rhodopsin and RDS genes in 17
different families with retinal dystrophiesl'2' and
appears to detect the same proportion of muta-
tions in screening of RP families as single strand
conformation polymorphism (SSCP)22 and
denaturing gradient gel electrophoresis
(DGGE).7
Linkage analysis was performed on markers
90
Figure 2 Goldmann field performed on the right eye of
subject IV-34 fromfamily 4.
within the rhodopsin and RDS genes in the
families. The rhodopsin poly-CA tract23 and the
RDS gene poly-T tract24 were amplified by the
polymerase chain reaction in symptomatic family
members. One primer in each amplification was
kinase end labelled with 32P-y ATP, then samples
were run on denaturing acrylamide gels. The gels
were dried and exposed to autoradiographic film
overnight. Inheritance of alleles relative to the
disease was analysed using the program LINK-
AGE, from the LINKAGE package version
5.10.25
Informed consent was obtained after the
nature of the procedures had been fully
explained.
Table 2 Affected patients: clinicalfindings
Acuity Goldmann fields
Family Subject Age (R;L) Cataract Maculae (IV4e target) Electroretinogram
1 III-S 34 6/18;6/18 Yes MO 10 degrees Non-recordable
1 IV-3 18 6/18;6/12 No MH 20 degrees Non-recordable
1 III-4 30 6/36;6/36 Yes MA 10 degrees Non-recordable
1 II-5 42 6/18;6/24 Yes MO 10 degrees Non-recordable
2 VIII-12 39 6/12;6/12 Yes MO 10 degrees Not performed
2 VIII-47 13 615;6/5 No Normal 10 degrees Absent rod, minimal cone responses
2 VII-25 58 6/36;NPL Yes MA 5 degrees Not performed
2 VIII-30 19 6/9;6/9 No Normal 40 degrees Rod and cone responses
2 VIII-31 22 616;6/6 No Normal 40 degrees Rod and cone responses
2 VII-28 33 6/18;6/12 Yes MO 5 degrees Non-recordable
2 VII-26 42 6/18;6/18 Yes MA 5 degrees Not performed
2 VII-14 46 6/18;6/18 Yes MO 40 degrees Absent rod, reduced cone responses
2 VII-13 56 6/12;6/12 No MO 5 degrees Non-recordable
2 VII-17 24 615;6/5 No Normal Full* Non-recordable
3 IV-14 53 6/36;6/36 Yes MA 15 degrees Non-recordable
3 V-2 22 6/6;6/5 No Normal 60 degrees Non-recordable
4 IV-il 37 6/18;6/18 Yes MO 10 degrees Non-recordable
4 III-15 45 6/9;6/9 Yes Normal 5 degrees Not performed
4 IV-48 19 6/9;6/6 No Normal Full* Absent rod, reduced cone responses
4 IV-34 16 6/6;6/6 No Normal Full* Absent rod, reduced cone responses
4 IV-8 20 6/12;6/12 Yes MO 10 degrees Non-recordable
4 111-3 45 6/18;6/9 Yes MO 10 degrees Non-recordable
4 III-29 40 LP;LP Yes MA <5 degrees Not performed
4 III-19 18 LPt;6/5 No Normal Full* Absent rod, reduced cone responses
4 IV-43 21 6/6;616 No Normal Full* Non-recordable
MO=macular oedema.
MA=macular atrophy.
MH=macular hole.
*Field loss evident with smaller targets.
tRight optic nerve hypoplasia.
I
-IV4/1-4
1 IV4 not
seen
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Figure 3 Static perimetry with red (dominant wavelength
660 nm, subtending 0 9 degrees) target, performed on the
dark adapted right eye ofsubject IV-34 fromfamily 4. The
symbols represent the extent ofthreshold elevation relative to
normal in log units. Visual angle in degrees is indicated on the
vertical axis.
Results
SYMPTOMATIC FAMILY MEMBERS
Clinicalfeatures
In three families (1, 3, 4) all symptomatic mem-
bers had early onset of night blindness and
evidence of severe disease. Of the 15 patients
from these families 10 had onset of night blind-
60
Figure 4 Static perimetry
with greenlblue (dominant
wavelength 530 nm,
subtending 0-9 degrees)
target, performed on the
dark adapted right eye of
subject IV-34 from family
4. The symbols represent the
extent of threshold elevation
relative to normal in log
units. Visual angle in
degrees is indicated on the
vertical axis. 90
ness before the age of 10 years and in four the
onset was before the age of 20 years. One denied
symptoms of night blindness. In the fourth
family (family 2) there was a more variable onset
of symptoms with half the patients developing
night blindness after the age of 20 years (Table
1). The results of the clinical examination are
shown in Table 2. In the majority ofpatients with
reduced acuity, this was due to posterior subcap-
sular lens opacities or macular oedema or atrophy
or a combination of these three factors. Macular
oedema was present in 17 eyes, 26 of the 50 eyes
had posterior subcapsular lens opacities, and one
eye was aphakic. The typical fundus features of
RP were seen in all 50 eyes.
Psychophysical testing and electroretinography
Scotopic and photopic visual field testing showed
extensive loss of rod and cone function in most
subjects tested. Only one affected individual over
the age of 25 had a visual field greater than 20
degrees to the larger target (IV 4e) of the
Goldmann perimeter. Although field loss was
greater with increasing age, severe field loss was
also seen in young family members (Table 2).
There were interfamilial and intrafamilial differ-
ences in severity. In family 1 all affected family
members tested, including one 18 year old
subject, had extensive field loss and this pattern
of severe disease was also seen in family 4. Dark
adapted static perimetry performed in four mem-
bers of family 1 and eight members of family 4,
similarly showed widespread elevation ofrod and
cone thresholds throughout the retina even in
young family members (Figs 2, 3, 4).
The threshold elevations were such that classi-
fication into diffuse (type 1) or regional (type 2)
disease'2 was not possible. In family 3 only one
affected individual underwent dark adapted
static perimetry and this again showed wide-
spread and marked rod and cone threshold
elevations. In these three families no subject had
rod or cone thresholds within 1 log unit ofnormal
in any area of the visual field tested. In contrast,
in family 2, there was more variation in the
severity of disease. One 13 year old boy had
visual fields, on Goldmann perimetry (IV 4e
target) reduced to 10 degrees whereas other older
symptomatic family members had well preserved
fields to the same target (Table 2). Similarly
scotopic perimetry showed widespread and
severe rod and cone threshold elevations in some
subjects while in others there were some areas of
the visual field with normal or only mildly
elevated rod and cone thresholds. In subjects
with mild disease there was patchy loss ofrod and
cone function consistent with the regional
pattern of disease described by Lyness et al.2
Electroretinography showed similar inter-
familial variation (Table 2). In families 1, 3, and 4
there were no identifiable rod responses in any
subject and most showed non-recordable cone
responses. Two subjects from family 4 had
delayed cone implicit times. In family 2 the ERG
responses were consistent with-the findings on
psychophysical testing. Two subjects with mild
disease showed well preserved rod and cone
responses, and all subjects with recordable cone
responses had normal cone b wave implicit times.
Log elevation
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Figure 5 Goldmannfield performed on the right eye of
subject III-25fromfamily 4.
ASYMPTOMATIC OBLIGATE GENE CARRIERS
Clinicalfindings
All six subjects had normal visual acuity, normal
fundus examination, and normal Goldmann
fields to the larger target (IV 4e) used (Fig 5).
Three subjects showed mild peripheral constric-
tion and in two there were small mid peripheral
scotomas to smaller targets (Table 3).
Electrophysiological andpsychophysical testing
The light rise of the EOG showed a mild
reduction in one or both eyes in three subjects
(Table 3). The amplitudes of flash ERG were
normal in five subjects and in one both scotopic
and photopic responses were just below 2 SD
from normal. Cone b wave implicit times were
prolonged in two subjects (Table 4). Dark
adapted perimetry showed normal rod and cone
responses at most of the retinal locations studied
but in each subject there were mild rod threshold
elevations (maximum threshold elevation 1-2-
1-9 log units) in at least one location. The results
from a typical subject are shown in Figures 6 and
7, which can be compared with those of his 16
year old affected son (Figs 3 and 4). Flicker
sensitivity was reduced in three subjects partic-
ularly at high frequencies (Table 4).
Table 3 Asymptomatic obligate gene cariers: results ofperimetry, photopicflicker, and
electro-oculography (EOG)
Family Subject Age Goldmann perimetry EOG(R/L) Photopicflicker
1 11-3 60 Scotoma I-2e isoptre 241/161 Normal*
1 111-3 39 Peripheral constriction 250/271 Relative high frequency
I-4e isoptre loss >2 SD
2 VII-41 40 Peripheral constriction 180/157 Normal*
I-2e isoptre
3 IV-4 49 Normal 258/235 Normal*
4 111-25 41 Small scotoma I-4e 150/170 Relative high frequency
target loss >2 SD
4 III-27 49 Peripheral constriction 200/218 Relative high frequency
I-2e target loss >2 SD
*Although photopic flicker was within 2 SD ofnormal it was selectively reduced at the higher
frequencies beyond 1 SD from normal.
MOLECULAR GENETICS OF THE FAMILIES
No mutations of the rhodopsin or RDS genes
were found in any of the four families using the
hydrolink heteroduplex method. In families 2, 3,
and 4 crossovers occurred between intragenic
markers within the rhodopsin gene and all four
families showed crossovers with markers within
theRDS gene, providing further evidence for the
exclusion of these genes as the disease locus.
Family 2 provided data excluding linkage (lod
score <-2-0) to rhodopsin and RDS at genetic
distances of 3 and 4 cM respectively. Families 3
and 4 proved less informative, but did show one
and two crossovers respectively with the rho-
*dopsin marker and two crossovers each with the
RDS marker, significantly excluding the im-
mediate genetic loci. Similarly, in family 1 one
crossover was observed with the RDS marker;
the rhodopsin polymorphism was uninformative
in this family.
Discussion
In some autosomal dominant disorders indi-
viduals known to be carrying the abnormal gene,
because of the presence of an affected offspring
and parent, may show no evidence ofthe disease.
This non-penetrance may be complete but often
subtle signs of the disease may be apparent on
careful examination and investigation or may
develop with increasing age. The borderline
between mild expression of a gene and non-
penetrance may therefore be difficult to define,
especially in a disease such as adRP which may
show a wide range of expression which is usually
age dependent. Although non-penetrance has
been described in adRP, there have been few
Log elevation
* > 3-0 A 06-1-0
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Figure 6 Static perimetry with red (dominant wavelength
660 nm, subtending 0 9 degrees) target, performed on the
dark adapted right eye ofsubject III-25fromfamily 4. The
symbols represent the extent ofthreshold elevation relative to
normal in log units. Visual angle in degrees is indicated on the
vertical axis.
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Figure 7 Static perimetry with green/blue (dominant
wavelength 530 nm, subtending 0 9 degrees) target,
performed on the dark adapted right eye ofsubject III-25
fromfamily 4. The symbols represent the extent ofthreshold
elevation relative to normal in log units. Visual angle in
degrees is indicated on the vertical axis.
systematic studies of such families. Berson et al"
studied one family with incomplete penetrance
and suggested on the basis of the electro-
retinographic findings that this was distinct from
other forms of adRP showing complete pene-
trance. In their family and two others reported
subsequently'2 young symptomatic individuals
showed substantially delayed cone implicit
times. Two asymptomatic individuals age 42 and
75 years with the abnormal gene had a normal
ERG and normal rod thresholds at the one
location tested suggesting that they showed true
non-penetrance ofthe gene. The younger patient
tested 10 years later retained a normal full field
ERG.12 The families we have studied are similar
to those reported by Berson and Simonoff"2 in
Table 4 Asymptomatic obligate gene carriers: amplitude and implicit times oftheflash ERG
Scotopic blue Brightflash white Flicker (30 Hz)
Subject
Family eye b amp b imp a amp a imp b amp b imp b amp b imp
1 II-3 R 190 70 180 15 200 55 38 33
L 160 80 160 15 200 55 16 33
1 III-3 R 270 60 160 15 260 55 32 31
L 250 60 120 15 360 55 32 31
2 VII-41 R 60 60 120 16 80 50 30 35
L 50 60 120 16 80 50 30 35
3 IV-4 R 260 70 140 15 330 50 35 31
L 225 68 140 16 360 52 40 31
4 III-25 R 260 66 200 15 240 50 25 32
L 230 66 200 14 360 48 30 30
4 III-27 R 180 60 240 15 240 50 25 32
L 140 60 200 15 360 48 30 30
Normal mean 319 57 262 15 404 50 43 29
Normal-2 SD 141 69 133 20 227 56 10 32
R=right eye.
L=left eye.
a amp=amplitude a wave in microvolts.
a imp=implicit time a wave in milliseconds.
b amp=amplitude b wave in microvolts.
b imp=implicit time b wave in milliseconds.
that some family members with the abnormal
gene are asymptomatic and have a normal fundus
appearance at an age when they would be
expected to show clear signs of the disease.
Although these 'skipped individuals' were
normal on the basis of routine clinical testing, in
contrast to the subjects reported by Berson et al"
and Berson and Simonoff" we have been able to
show that all six subjects show mild electro-
physiological or psychophysical abnormalities of
retinal function in some retinal locations. The
most consistent abnormality was elevated rod
thresholds on dark adapted perimetry. The find-
ing of abnormal cone implicit times on electro-
retinography and elevated photopic fficker
thresholds in some subjects is consistent with the
suggestion of Berson and Simonoff" that there
may be early peripheral cone involvement in this
form of adRP.
In our families we have shown functional
abnormalities in all members known to have the
abnormal gene indicating that there is variable
expression of the mutant gene rather than true
non-penetrance. The question arises whether or
not such families represent one or more distinct
subtypes ofadRP. On the basis of the findings in
the asymptomatic obligate gene carriers they can
be classified as type II or regional (R) type adRP'2
but differ from other R type families we have
studied both in the severity of disease seen in
young symptomatic family members and in the
wide range of disease severity. Although there is
some interfamilial variability in the pedigrees
reported here, they share many similarities, and
it is possible that they may be caused by muta-
tions at a single locus. Variations in the pattern of
retinal dysfunction have been shown to be com-
mon with different mutations in the rhodopsin
gene2"32 and similar allelic heterogeneity may be
seen in other genetic disorders.33 We have
demonstrated that our families do not have
mutations of the rhodopsin or RDS genes but
this does not exclude the possibility that muta-
tions of gene promoters or other related regula-
tory regions may be responsible. However, in
three families we have excluded linkage to known
loci on chromosomes 3 and 6 indicating that
other genetic loci are involved. Whether or not
such a wide range of expressions are caused by
mutations at a single locus will depend upon the
demonstration of the genetic defects.
One might expect families showing apparent
incomplete penetrance to be those with mild
disease of late onset, with the 'skipped indi-
viduals' being at the milder end of the disease
spectrum. However, we have shown that symp-
tomatic individuals have severe disease often of
early onset. There must therefore be other
factors, either genetic or environmental, that
influence expression of the mutant gene. The
extreme intrafamilial variation, with younger
individuals often being severly affected, seen in
our families make an environmental influence
unlikely. Examination of the pedigree structure
provides no evidence for anticipation' or
genomic imprinting effects35 and it seems more
likely that other 'modifying' loci are responsible
for influencing expression of the primary mutant
gene. The identification of these genetic inter-
actions remains a major challenge.
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